chr5-157285369-C-T

Variant summary

Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PP2BP4BP6BS2

The NM_001037333.3(CYFIP2):​c.8C>T​(p.Thr3Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000894 in 1,566,304 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000092 ( 0 hom. )

Consequence

CYFIP2
NM_001037333.3 missense

Scores

4
3
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 7.71
Variant links:
Genes affected
CYFIP2 (HGNC:13760): (cytoplasmic FMR1 interacting protein 2) Predicted to enable small GTPase binding activity. Involved in activation of cysteine-type endopeptidase activity; apoptotic process; and cell-cell adhesion. Located in perinuclear region of cytoplasm and synapse. Part of SCAR complex. Implicated in developmental and epileptic encephalopathy 65. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -5 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), CYFIP2. . Gene score misZ: 6.0129 (greater than the threshold 3.09). Trascript score misZ: 6.9267 (greater than threshold 3.09). The gene has 20 curated pathogenic missense variants (we use a threshold of 10). The gene has 46 curated benign missense variants. GenCC has associacion of the gene with developmental and epileptic encephalopathy, 65, developmental and epileptic encephalopathy, 76, undetermined early-onset epileptic encephalopathy.
BP4
Computational evidence support a benign effect (MetaRNN=0.37277308).
BP6
Variant 5-157285369-C-T is Benign according to our data. Variant chr5-157285369-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 2440664.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=1}.
BS2
High AC in GnomAdExome4 at 13 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CYFIP2NM_001037333.3 linkc.8C>T p.Thr3Met missense_variant 2/31 ENST00000620254.5 NP_001032410.1 Q96F07-2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CYFIP2ENST00000620254.5 linkc.8C>T p.Thr3Met missense_variant 2/311 NM_001037333.3 ENSP00000479968.1 Q96F07-2

Frequencies

GnomAD3 genomes
AF:
0.00000657
AC:
1
AN:
152204
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000919
AC:
13
AN:
1414100
Hom.:
0
Cov.:
31
AF XY:
0.0000114
AC XY:
8
AN XY:
698758
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000270
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000920
Gnomad4 OTH exome
AF:
0.0000341
GnomAD4 genome
AF:
0.00000657
AC:
1
AN:
152204
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
74362
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000564
Hom.:
0
Bravo
AF:
0.0000151

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Developmental and epileptic encephalopathy, 65 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingRevvity Omics, RevvityMar 24, 2021- -
not provided Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 02, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.24
BayesDel_addAF
Benign
-0.052
T
BayesDel_noAF
Benign
-0.31
CADD
Pathogenic
29
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.17
T;.;.;T;T;T;.;.;.
Eigen
Uncertain
0.57
Eigen_PC
Uncertain
0.65
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Pathogenic
0.98
D;.;D;D;D;D;D;D;D
M_CAP
Benign
0.0091
T
MetaRNN
Benign
0.37
T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
0.90
L;L;.;.;.;.;.;.;L
PrimateAI
Pathogenic
0.85
D
PROVEAN
Benign
-1.9
.;.;N;.;N;.;.;.;.
REVEL
Benign
0.15
Sift
Benign
0.034
.;.;D;.;D;.;.;.;.
Sift4G
Uncertain
0.035
D;D;T;D;D;D;D;D;D
Polyphen
0.98
D;D;P;.;D;.;.;.;D
Vest4
0.38
MutPred
0.40
Loss of glycosylation at T3 (P = 0.0059);Loss of glycosylation at T3 (P = 0.0059);Loss of glycosylation at T3 (P = 0.0059);Loss of glycosylation at T3 (P = 0.0059);Loss of glycosylation at T3 (P = 0.0059);Loss of glycosylation at T3 (P = 0.0059);Loss of glycosylation at T3 (P = 0.0059);Loss of glycosylation at T3 (P = 0.0059);Loss of glycosylation at T3 (P = 0.0059);
MVP
0.27
MPC
1.5
ClinPred
0.62
D
GERP RS
5.6
Varity_R
0.26
gMVP
0.83

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1241752177; hg19: chr5-156712379; API